NAFLD Summit - Geneva 20-22 September, 2018

NAFLD Summit 2018

Key deadlines

Abstract submission26 June 2018 Add to my agenda

Early registration deadline 23 July 2018 Add to my agenda


We would like to cordially invite you to the EASL Non-Alcoholic Fatty Liver Disease (NAFLD) Summit 2018 to be held from 20-22 September 2018 in Geneva, Switzerland.


view the scientific programme


NAFLD is the leading cause of chronic liver disease not only in Western countries but also among developing countries of the Far East, South Asia, the Middle East, and Latin America. In the US and Europe, nearly 40% of the population have NAFLD and approximately 20% of these individuals are likely to develop progressive liver disease (i.e. NASH) that lead to liver fibrosis and cirrhosis. Another emerging challenge is hepatocellular cancer which increasingly arises in precirrhotic stages. Although a significant number of new drugs are already in the development pipeline, none are as yet, approved by regulatory agencies. As such, the identification and development of new therapies is urgently needed.

For more information visit website.


Help us to inform the liver community by downloading the flyer, printing it and placing it on your institute's notice board:

Download flyer



Supported by AbbVie, Bristol-Myers Squibb and MSD.

AbbVie, Bristol-Myers Squibb and MSD have had no input into the content of the materials and presentations used at this event.


Sponsorship and exhibition opportunities

Partnership opportunities are available for the NAFLD summit 2018. For full details contact us.

   View the Exhibition floor plan